Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin in Children With Recurrent Solid Tumors
NCT00091182Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Oct 2004
- Primary completion
- Feb 2006
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in solid tumor, sponsored by National Cancer Institute. Started Oct 2004; status: completed.
02
Drugs
oxaliplatin
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT00091182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00091182.